2024 Annual Report

The 2024 Annual Report highlights a year of strategic growth, expanded research, and a strengthened focus on patient-centered and equity-driven value research following the organization’s rebrand as IVI.

2025 Methods Summit Report

This summary report captures the insights from the 6th Annual Methods Summit convened by IVI, which focused on advancing patient-centered value research from definition through dissemination.

2024 Methods Summit Summary

This summary report captures insights from the 5th Annual IVI Methods Summit, which focused on the future of patient-centered health technology assessment (HTA).

Valuing Rare Disease Treatments in Healthcare: Real Experience, Real Impact

This report, developed by the Innovation and Value Initiative and the EveryLife Foundation for Rare Diseases, outlines how comparative effectiveness research, patient-centered outcomes research, and value assessment must evolve to better reflect what matters to people living with rare diseases and their caregivers.